Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/158652
Full metadata record
DC FieldValueLanguage
dc.creatorDiogo Alcino de Abreu Ribeiro Carvalho Machado
dc.date.accessioned2026-01-13T10:12:04Z-
dc.date.available2026-01-13T10:12:04Z-
dc.date.issued2010-07-28
dc.date.submitted2024-05-16
dc.identifier.othersigarra:672121
dc.identifier.urihttps://hdl.handle.net/10216/158652-
dc.language.isopor
dc.rightsopenAccess
dc.subjectCiências da saúde
dc.subjectHealth sciences
dc.titleMyelodysplastic Syndromes - Therapeutic options in high-risk patients
dc.typeDissertação
dc.contributor.uportoInstituto de Ciências Biomédicas Abel Salazar
dc.identifier.doi10.34626/7tq9-b825
dc.subject.fosCiências médicas e da saúde::Ciências da saúde
dc.subject.fosMedical and Health sciences::Health sciences
thesis.degree.disciplineMestrado Integrado em Medicina
thesis.degree.grantorInstituto de Ciências Biomédicas Abel Salazar
thesis.degree.grantorUniversidade do Porto
thesis.degree.level1
Appears in Collections:ICBAS - Dissertação

Files in This Item:
File Description SizeFormat 
672121.pdfMyelodysplastic Syndromes - Therapeutic options in high-risk patients886.95 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.